Mirikizumab, CAS 1884201-71-1

Product Description: Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Jefremow A, et al. Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical Perspective. Immunotargets Ther. 2020 Nov 26;9:289-297.

CAS Number: 1884201-71-1

Molecular Weight: N/A

Compound Purity: 98.15

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99737-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99737-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated